These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 35388973)
21. EMMPRIN expression is associated with metastatic progression in osteosarcoma. Kim HS; Kim HJ; Lee MR; Han I BMC Cancer; 2021 Sep; 21(1):1059. PubMed ID: 34565336 [TBL] [Abstract][Full Text] [Related]
22. Identification of MCM4 and PRKDC as new regulators of osteosarcoma cell dormancy based on 3D cell cultures. Jubelin C; Muñoz-Garcia J; Ollivier E; Cochonneau D; Vallette F; Heymann MF; Oliver L; Heymann D Biochim Biophys Acta Mol Cell Res; 2024 Mar; 1871(3):119660. PubMed ID: 38216092 [TBL] [Abstract][Full Text] [Related]
23. Lupeol inhibits osteosarcoma progression by up-regulation of HMGA2 via regulating miR-212-3p. Zhong J; He C; Xu F; Xu X; Liu L; Xu M; Guo Z; Wang Y; Liao J; Li Y J Orthop Surg Res; 2020 Sep; 15(1):374. PubMed ID: 32883329 [TBL] [Abstract][Full Text] [Related]
24. [Expression of Ether à go-go 1 and its molecular mechanism of regulating the malignant phenotype of osteosarcoma]. Chen ZD; Liu QJ; Zeng WR; Wu XY; Lin B; Wu J Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):818-825. PubMed ID: 27998439 [No Abstract] [Full Text] [Related]
25. Deletion of Aoki Y; Tome Y; Han Q; Yamamoto J; Hamada K; Masaki N; Kubota Y; Bouvet M; Nishida K; Hoffman RM Cancer Genomics Proteomics; 2022; 19(3):299-304. PubMed ID: 35430564 [TBL] [Abstract][Full Text] [Related]
26. Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma. Ma H; Dean DC; Wei R; Hornicek FJ; Duan Z Ther Adv Musculoskelet Dis; 2021; 13():1759720X21995069. PubMed ID: 34104229 [TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma. Su Y; Wagner ER; Luo Q; Huang J; Chen L; He BC; Zuo GW; Shi Q; Zhang BQ; Zhu G; Bi Y; Luo J; Luo X; Kim SH; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Yang K; Wietholt C; Li M; Qin J; Haydon RC; He TC; Luu HH Oncogene; 2011 Sep; 30(37):3907-17. PubMed ID: 21460855 [TBL] [Abstract][Full Text] [Related]
28. Establishment of new multidrug-resistant human osteosarcoma cell lines. Oda Y; Matsumoto Y; Harimaya K; Iwamoto Y; Tsuneyoshi M Oncol Rep; 2000; 7(4):859-66. PubMed ID: 10854558 [TBL] [Abstract][Full Text] [Related]
29. Upregulation of 15 Antisense Long Non-Coding RNAs in Osteosarcoma. Rothzerg E; Ho XD; Xu J; Wood D; Märtson A; Kõks S Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440306 [TBL] [Abstract][Full Text] [Related]
30. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p. Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551 [TBL] [Abstract][Full Text] [Related]
31. SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma. Guo T; Wei R; Dean DC; Hornicek FJ; Duan Z Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34984436 [TBL] [Abstract][Full Text] [Related]
32. The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines. Lucero CM; Vega OA; Osorio MM; Tapia JC; Antonelli M; Stein GS; van Wijnen AJ; Galindo MA J Cell Physiol; 2013 Apr; 228(4):714-23. PubMed ID: 22949168 [TBL] [Abstract][Full Text] [Related]
33. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis. Liu ZB; Wang JA; Lv RQ Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262 [TBL] [Abstract][Full Text] [Related]
34. CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma. Han Q; Li C; Cao Y; Bao J; Li K; Song R; Chen X; Li J; Wu X Cancer Med; 2019 Jul; 8(8):3981-3991. PubMed ID: 31150156 [TBL] [Abstract][Full Text] [Related]
35. Knockdown of CD44 inhibits proliferation, migration and invasion of osteosarcoma cells accompanied by downregulation of cathepsin S. Kong L; Ji H; Gan X; Cao S; Li Z; Jin Y J Orthop Surg Res; 2022 Mar; 17(1):154. PubMed ID: 35264209 [TBL] [Abstract][Full Text] [Related]
36. Downregulation of 14-3-3β inhibits proliferation and migration in osteosarcoma cells. Wu Q; Zhu J; Liu F; Liu J; Li M Mol Med Rep; 2018 Feb; 17(2):2493-2500. PubMed ID: 29207109 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway. Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089 [TBL] [Abstract][Full Text] [Related]
38. Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells. Roepke M; Diestel A; Bajbouj K; Walluscheck D; Schonfeld P; Roessner A; Schneider-Stock R; Gali-Muhtasib H Cancer Biol Ther; 2007 Feb; 6(2):160-9. PubMed ID: 17218778 [TBL] [Abstract][Full Text] [Related]
39. Autophagy prevents doxorubicin‑induced apoptosis in osteosarcoma. Zhao D; Yuan H; Yi F; Meng C; Zhu Q Mol Med Rep; 2014 May; 9(5):1975-81. PubMed ID: 24639013 [TBL] [Abstract][Full Text] [Related]
40. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3. Tan Y; Chen L; Li S; Hao H; Zhang D Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]